Search results for "Mononuclear"

showing 10 items of 438 documents

The pyrrole moiety as a template for COX-1/COX-2 inhibitors

2000

Aroyl- and thiophene-substituted pyrrole derivatives have been synthesized as a new class of COX-1/COX-2 inhibitors. The inhibition of COX-1 was evaluated in a biological system using bovine PMNLs as the enzyme source, whereas LPS-stimulated human monocytes served as the enzyme source for inducible COX-2. The determination of the concentration of arachidonic acid metabolites was performed by HPLC for COX-1 and RIA for COX-2. Variation of the substitution pattern led to a series of active compounds which showed inhibition for COX-1 and COX-2. Structural requirements for the development of COX-1/COX-2 inhibitors are discussed.

DiclofenacNeutrophilsStereochemistryIndomethacinThiophenesHigh-performance liquid chromatographyMonocytesPyrrole derivativeschemistry.chemical_compoundDrug DiscoveryAnimalsHumansStructure–activity relationshipMoietyCyclooxygenase InhibitorsPyrrolesSulfonesPyrrolePharmacologychemistry.chemical_classificationArachidonic AcidCyclooxygenase 2 InhibitorsMolecular StructureAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryMembrane ProteinsGeneral MedicineIsoenzymesEnzymechemistryMembrane proteinBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesCyclooxygenase 1Leukocytes MononuclearCattleArachidonic acidEuropean Journal of Medicinal Chemistry
researchProduct

Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)/K(+)-ATPase.

2015

Cardiotonic steroids have long been in clinical use for treatment of heart failure and are now emerging as promising agents in various diseases, especially cancer. Their main target is Na(+)/K(+)-ATPase, a membrane protein involved in cellular ion homeostasis. Na(+)/K(+)-ATPase has been implicated in cancer biology by affecting several cellular events and signaling pathways in both sensitive and drug-resistant cancer cells. Hence, we investigated the cytotoxic activities of 66 cardiotonic steroids and cardiotonic steroid derivatives in sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells. Data were then subjected to quantitative structure-activity relationship analysis (QSA…

DigoxinCell SurvivalEndocrinology Diabetes and MetabolismClinical BiochemistryPrimary Cell CultureGene ExpressionQuantitative Structure-Activity RelationshipAntineoplastic AgentsBiologyPharmacologyBiochemistryCardiac GlycosidesEndocrinologyCellular ion homeostasisCell Line TumorCytotoxic T cellHumansNa+/K+-ATPaseCytotoxicityMolecular BiologyCell BiologyMolecular biologyDrug Resistance MultipleBlotBufanolidesMolecular Docking SimulationVerapamilCell cultureDoxorubicinDrug Resistance NeoplasmCancer cellLeukocytes MononuclearMolecular MedicineSignal transductionSodium-Potassium-Exchanging ATPaseSignal TransductionThe Journal of steroid biochemistry and molecular biology
researchProduct

Flupirtine protects both neuronal cells and lymphocytes against induced apoptosis in vitro: Implications for treatment of AIDS patients

1999

In the present study we demonstrate that flupirtine, an already clinically used, centrally acting, non-opiate analgesic agent, protects rat cortical neurons against HIV-gp120 induced apoptotic cell death. The drug was active at concentrations between 1 and 10 microg/ml. Furthermore we show inhibition of in vitro induced apoptosis in human blood mononuclear cells, using flupirtine. Induced apoptosis in peripheral blood mononuclear cells from healthy individuals and HIV-1 infected patients was reduced to approximately 50% after in vitro preincubation with flupirtine at concentrations between 0.1 and 10 microg/ml. The anti-apoptotic effect of flupirtine was restricted to CD3+ lymphocytes and i…

DrugAids patientsbiologybusiness.industryCD3media_common.quotation_subjectAnalgesicCell BiologyPharmacologyPeripheral blood mononuclear cellIn vitroApoptosisbiology.proteinMedicineFlupirtinebusinessMolecular Biologymedia_commonmedicine.drugCell Death & Differentiation
researchProduct

The 2-5A System and HIV Infection

1994

The human immunodeficiency virus type 1 (HIV-1) is the etiologic agent of acquired immunodeficiency syndrome (AIDS). The progression of this retro viral disease is associated with various clinical manifestations, including the acquisition of an immunodeficient state, the frequent presence of neurological disorders, and some malignancies (reviewed in Barre-Sinoussi et al. 1983; Wong-Staal and Gallo 1985; Fauci 1988). Immunologic dysfunctions caused by HIV-1 infection include disorders in the production of cytokines (Murray et al. 1984; Abb et al. 1986). For example, a significant decrease in the production of interferon-α (IFN-α) by cultured peripheral blood mononuclear cells (PBMC) from pat…

EIF-2 kinasebiologyAcquired immunodeficiency syndrome (AIDS)RNase Pbiology.proteinmedicineDiseaseViral diseaseReceptormedicine.diseasePeripheral blood mononuclear cellVirologyRibonuclease L
researchProduct

Enrichment of Outgrowth Endothelial Cells in High and Low Colony-Forming Cultures from Peripheral Blood Progenitors

2009

An effective isolation protocol for outgrowth endothelial cells (OEC) resulting in higher cell numbers and a reduced expansion time would facilitate the therapeutical application. In this study a standard protocol based on the isolation of mononuclear cells from adult peripheral blood was modified by adding a passaging step 7 days after the isolation. OEC colonies gained by both protocols were evaluated after 28 days and resulted in different frequencies of OEC colonies depending on the donor and culture protocol. Accordingly, we defined two groups, namely, high colony-forming cultures (HCC) and low colony-forming cultures (LCC) for further analysis. LCC revealed no increase in OEC colonies…

EndotheliumBiomedical EngineeringCD34Fluorescent Antibody TechniqueGene ExpressionMedicine (miscellaneous)BioengineeringBiologyPolymerase Chain ReactionPeripheral blood mononuclear cellArticleFlow cytometrymedicineHumansEndotheliumProgenitor cellClonogenic assayCells CulturedCell Proliferationmedicine.diagnostic_testCell growthStem CellsFlow CytometryMolecular biologymedicine.anatomical_structureStem cellCell DivisionTissue Engineering Part C: Methods
researchProduct

Abacavir and didanosine induce the interaction between human leukocytes and endothelial cells through Mac-1 upregulation

2010

Objective: Abacavir and didanosine are nucleoside reverse transcriptase inhibitors (NRTI) widely used in therapy for HIV-infection but which have been linked to cardiovascular complications. The objective of this study was to analyze the effects of clinically relevant doses of abacavir and didanosine on human leukocyte―endothelium interactions and to compare them with those of other NRTIs. Design and methods: The interactions between human leukocytes ― specifically peripheral blood polymorphonuclear (PMN) or mononuclear (PBMC) cells ― and human umbilical vein endothelial cells were evaluated in a flow chamber system that reproduces conditions in vivo. The expression of adhesion molecules wa…

EndotheliumImmunologyMacrophage-1 AntigenCell CommunicationPharmacologyBiologyPeripheral blood mononuclear cellZidovudineimmune system diseasesAbacavirLeukocytesmedicineHumansImmunology and AllergyDidanosineAnalysis of VarianceCell adhesion moleculeEndothelial Cellsvirus diseasesLamivudineDideoxynucleosidesUp-RegulationEndothelial stem cellDidanosineInfectious Diseasesmedicine.anatomical_structureCardiovascular DiseasesImmunologyReverse Transcriptase InhibitorsEndothelium VascularCell Adhesion Moleculesmedicine.drugAIDS
researchProduct

Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte–endothelial cell interactions

2015

AbstractEnhanced leukocyte recruitment is an inflammatory process that occurs during early phases of the vascular dysfunction that characterises atherosclerosis. We evaluated the impact of anti-TNF-α (adalimumab, infliximab and etanercept) and anti-IL-12/23 (ustekinumab) on interactions between human leukocytes and endothelial cells in a flow chamber that reproduced in vivo conditions. Clinical concentrations of anti-TNF-α were evaluated on the leukocyte recruitment induced by a variety of endothelial (TNF-α, interleukin-1β, lymphotoxin-α and angiotensin-II) and leukocyte (PAF, IL-12 and IL-23) stimuli related to inflammation and atherosclerosis. Treatment with anti-TNF-α, even before or af…

EndotheliumInflammationAnti-IL-12/23 agentsCardiovascular side effectsBiologicsInterleukin-23Rheumatic diseasesIn vivoPsoriasisHuman Umbilical Vein Endothelial CellsInterleukin 23HumansMedicineAnti-TNF-α agentsPharmacologyTumor Necrosis Factor-alphabusiness.industryCell adhesion moleculeAdalimumabEndothelial Cellsmedicine.diseaseInterleukin-12Leukocyte–endothelial cell interactionsEndothelial stem cellmedicine.anatomical_structureImmunologyLeukocytes MononuclearTumor necrosis factor alphamedicine.symptombusinessEuropean Journal of Pharmacology
researchProduct

Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection

2012

The mechanisms resulting in progressive immune dysfunction during the chronic phase of HIV infection are not fully understood. We have previously shown that arginase, an enzyme with potent immunosuppressive properties, is increased in HIV seropositive (HIV+) patients with low CD4(+) T cell counts. Here we show that the cells expressing arginase in peripheral blood mononuclear cells of HIV+ patients are low-density granulocytes (LDGs) and that whereas these cells have a similar morphology to normal-density granulocyte, they are phenotypically different. Importantly, our results reveal that increased frequencies of LDGs correlate with disease severity in HIV+ patients.

Enzyme Metabolismlcsh:MedicineHIV InfectionsBiochemistryACTIVATION0302 clinical medicineImmunophenotypingImmunodeficiency VirusesRENAL-CELL CARCINOMAHIV SeropositivityMedicineSUPPRESSOR-CELLSlcsh:ScienceImmune ResponseCD180303 health scienceseducation.field_of_studyMultidisciplinarymedicine.diagnostic_testT Cellsvirus diseasesMiddle Aged3. Good healthEnzymesSEROPOSITIVE PATIENTSArginasemedicine.anatomical_structurePhenotypeHIV epidemiologyDisease ProgressionMedicineInfectious diseasesScience & Technology - Other TopicsNEUTROPHILResearch ArticleAdultGeneral Science & TechnologyT cellImmune CellsPopulationImmunologyCD18Viral diseasesGranulocytePeripheral blood mononuclear cellMicrobiologyFlow cytometryImmunophenotyping03 medical and health sciencesADHERENCEVirologyMD MultidisciplinaryHumanseducationBiology030304 developmental biologyScience & TechnologyArginasebusiness.industryTetraspanin 30MULTIDISCIPLINARY SCIENCESlcsh:RARGINASE-IHIVVirologyENDOTHELIAL-CELLSAntigens CD63ImmunologyLeukocytes Mononuclearlcsh:Qbusiness030215 immunologyGranulocytes
researchProduct

Anti-HIV-1 activity of inorganic polyphosphates.

1997

Human blood plasma, serum, peripheral blood mononuclear cells, and erythrocytes contain significant amounts of inorganic polyphosphates (ranging from 53 to 116 microM, in terms of phosphate residues). Here we demonstrate that at higher concentrations linear polyphosphates display cytoprotective and antiviral activity. Sodium tetrapolyphosphate and the longer polymers, with average chain lengths of 15, 34, and 91 phosphate residues, significantly inhibited human immunodeficiency virus type 1 (HIV-1) infection of cells in vitro at concentrations > or = 33.3 microg/ml (> or = 283-324 microM phosphate residues), whereas sodium tripolyphosphate was ineffective. In the tested concentration range,…

ErythrocytesCell SurvivalSodiumT-LymphocytesImmunologychemistry.chemical_elementBiologyPeripheral blood mononuclear cellGiant CellsCell LineCell Fusionchemistry.chemical_compoundDrug StabilityPolyphosphatesVirologyImmunology and AllergyHumansHost cell surfaceSyncytiumCell fusionDose-Response Relationship DrugPolyphosphateBiological activityPhosphateBiochemistrychemistryHIV-1Leukocytes MononuclearCell DivisionJournal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
researchProduct

AN IL-6/IL-6 SOLUBLE RECEPTOR (IL-6R) HYBRID PROTEIN (H-IL-6) INDUCES EPO-INDEPENDENT ERYTHROID DIFFERENTIATION IN HUMAN CD34+CELLS

2000

H-IL-6 is a hybrid protein constructed to contain IL-6 and its soluble receptor linked by a flexible peptide chain. Here we show that H-IL-6 strongly enhances proliferation of human CD34(+)cells in serum-free liquid culture, and that the majority of the cells generated belong to the erythroid lineage, being positive for the marker Glycophorin A. Conversely, H-IL-6 does not increase the number of myeloid, CD13-positive cells. Comparable effects are observed on progenitors from cord blood and adult peripheral blood. Therefore, H-IL-6 triggers an erythroid-inducing signal in haematopoietic progenitor cells, independently from erythropoietin (EPO).

ErythrocytesTime FactorsMyeloidCellular differentiationInterleukin 6Antigens CD34BiochemistryCulture Media Serum-FreeSerum-Freehemic and lymphatic diseasesReceptorsLeukocytesImmunology and AllergyErythropoiesisGlycophorinsStem Cell FactorbiologyChemistryCord bloodCell DifferentiationHematologyFetal BloodFlow CytometryEndothelial stem cellHaematopoiesismedicine.anatomical_structureGlycophorinCD34+medicine.drugRecombinant Fusion ProteinsMononuclearImmunologyCD13 AntigensmedicineHumansGlycophorinAntigensProgenitor cellErythropoietinMolecular BiologyInterleukin 3Interleukin-6CD34+; Cord blood; Erythropoiesis; Interleukin 6; Stem cell factor; Antigens CD34; CD13 Antigens; Cell Differentiation; Culture Media Serum-Free; Erythrocytes; Erythropoietin; Fetal Blood; Flow Cytometry; Glycophorin; Hematopoietic Stem Cells; Humans; Interleukin-6; Leukocytes Mononuclear; Peptides; Receptors Interleukin-6; Recombinant Fusion Proteins; Stem Cell Factor; Time Factors; Immunology and Allergy; Immunology; Biochemistry; Hematology; Molecular BiologyHematopoietic Stem CellsReceptors Interleukin-6Molecular biologyCulture MediaErythropoietinLeukocytes Mononuclearbiology.proteinCD34PeptidesCytokine
researchProduct